A detailed history of Centaurus Financial, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Centaurus Financial, Inc. holds 6,502 shares of TMO stock, worth $3.42 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
6,502
Previous 6,283 3.49%
Holding current value
$3.42 Million
Previous $3.47 Million 15.75%
% of portfolio
0.28%
Previous 0.25%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$531.86 - $624.21 $116,477 - $136,701
219 Added 3.49%
6,502 $4.02 Million
Q2 2024

Sep 20, 2024

BUY
$541.52 - $599.02 $108,845 - $120,403
201 Added 3.3%
6,283 $3.47 Million
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $79,851 - $90,513
151 Added 2.55%
6,082 $3.53 Million
Q4 2023

Feb 26, 2024

BUY
$431.41 - $532.94 $235,549 - $290,985
546 Added 10.14%
5,931 $3.15 Million
Q3 2023

Nov 13, 2023

BUY
$498.29 - $574.41 $414,078 - $477,334
831 Added 18.25%
5,385 $2.73 Million
Q2 2023

Aug 15, 2023

SELL
$508.46 - $591.13 $291,856 - $339,308
-574 Reduced 11.19%
4,554 $2.38 Million
Q1 2023

May 17, 2023

BUY
$535.0 - $604.82 $293,715 - $332,046
549 Added 11.99%
5,128 $2.96 Million
Q4 2022

Feb 10, 2023

SELL
$484.71 - $571.37 $344,628 - $406,244
-711 Reduced 13.44%
4,579 $2.52 Million
Q3 2022

Dec 05, 2022

BUY
$507.19 - $604.49 $201,354 - $239,982
397 Added 8.11%
5,290 $2.68 Million
Q2 2022

Aug 02, 2022

SELL
$500.9 - $612.21 $23,542 - $28,773
-47 Reduced 0.95%
4,893 $2.66 Million
Q1 2022

May 13, 2022

SELL
$524.0 - $644.92 $94,320 - $116,085
-180 Reduced 3.52%
4,940 $2.92 Million
Q4 2021

Feb 01, 2022

SELL
$569.0 - $667.24 $25,605 - $30,025
-45 Reduced 0.87%
5,120 $3.42 Million
Q3 2021

Nov 12, 2021

BUY
$509.53 - $609.78 $46,367 - $55,489
91 Added 1.79%
5,165 $2.95 Million
Q2 2021

Aug 10, 2021

BUY
$441.0 - $508.24 $1.89 Million - $2.18 Million
4,294 Added 550.51%
5,074 $2.56 Million
Q1 2021

Apr 30, 2021

BUY
$439.85 - $518.83 $41,785 - $49,288
95 Added 13.87%
780 $356,000
Q4 2020

Jan 25, 2021

SELL
$435.06 - $527.66 $21,753 - $26,383
-50 Reduced 6.8%
685 $319,000
Q3 2020

Nov 12, 2020

BUY
$359.77 - $441.52 $69,435 - $85,213
193 Added 35.61%
735 $324,000
Q2 2020

Aug 13, 2020

BUY
$275.2 - $362.34 $9,907 - $13,044
36 Added 7.11%
542 $196,000
Q1 2020

Apr 21, 2020

BUY
$255.3 - $340.05 $2,808 - $3,740
11 Added 2.22%
506 $144,000
Q4 2019

Feb 12, 2020

BUY
$271.93 - $328.04 $134,605 - $162,379
495 New
495 $161,000
Q3 2019

Nov 12, 2019

SELL
$268.46 - $305.43 $270,607 - $307,873
-1,008 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$257.51 - $295.55 $190,299 - $218,411
739 Added 274.72%
1,008 $296,000
Q1 2019

Jul 01, 2019

SELL
$212.17 - $273.72 $151,489 - $195,436
-714 Reduced 72.63%
269 $983,000
Q1 2019

May 13, 2019

BUY
$212.17 - $273.72 $149,155 - $192,425
703 Added 251.07%
983 $269,000
Q4 2018

Feb 12, 2019

BUY
$208.47 - $251.98 $58,163 - $70,302
279 Added 27900.0%
280 $1,000
Q3 2018

Nov 05, 2018

SELL
$205.57 - $244.32 $307,943 - $365,991
-1,498 Reduced 99.93%
1 $366,000
Q2 2018

Aug 15, 2018

BUY
$203.14 - $219.53 $27,830 - $30,075
137 Added 10.06%
1,499 $311,000
Q1 2018

May 07, 2018

BUY
$192.98 - $224.11 $262,838 - $305,237
1,362 New
1,362 $281,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $206B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.